<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>) has been related to mutations associated with spinocerebellar <z:hpo ids='HP_0001251'>ataxias</z:hpo> (SCA); the frequency of the diagnosis of these mutations is low in general <z:hpo ids='HP_0003584'>late-onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> cases </plain></SENT>
<SENT sid="1" pm="."><plain>Our aim was to investigate a selected high-risk group of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> patients </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> patients with <z:hpo ids='HP_0000006'>autosomal dominant inheritance</z:hpo> or atypical neurological manifestations were enrolled, underwent a full neurological examination and had the CAG tracts of their <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA1</z:e>, 2, 3, 6 and 7 genes analyzed </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Of the 23 studied families, two <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> and one SCA2 cases were identified </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> had <z:hpo ids='HP_0000006'>autosomal dominant inheritance</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>In the SCA2 pedigree, four affected sibs had a homogeneous <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> phenotype </plain></SENT>
<SENT sid="6" pm="."><plain>CAG repeats varied between 35 and 44 with CAA interruptions </plain></SENT>
<SENT sid="7" pm="."><plain>Intrafamilial phenotypic <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> was identified in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> pedigrees; parkinsonian and ataxic phenotypes coexisted in both kindreds </plain></SENT>
<SENT sid="8" pm="."><plain>CAGn varied between 69 and 71 repeats </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0011007'>Age of onset</z:hpo> was lower in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> patients than in the remaining 24 cases (38 versus 46.7+/-12 years of age, p=0.003) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: SCA2 and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> mutations were detected in 13% of the present sample: the strategy of selecting a high-risk group increased the rate of making these diagnoses </plain></SENT>
<SENT sid="11" pm="."><plain>The SCA2 cases confirmed an association between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> and interrupted expansions, as well as <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> intrafamilial phenotypic homogeneity </plain></SENT>
<SENT sid="12" pm="."><plain>Clinical <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> pedigrees suggests that disease-modifying agents outside the MJD1 gene may play a role in determining <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> symptoms in this disorder </plain></SENT>
</text></document>